相似文献
1
Zinc transporters in prostate cancer.前列腺癌中的锌转运体。
Mol Aspects Med. 2013 Apr-Jun;34(2-3):735-41. doi: 10.1016/j.mam.2012.11.007.
2
Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer.正常前列腺组织和前列腺癌组织中线粒体功能、锌与中间代谢的关系
Mitochondrion. 2005 Jun;5(3):143-53. doi: 10.1016/j.mito.2005.02.001.
3
hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.hZIP1锌摄取转运体下调与前列腺癌中的锌耗竭
Mol Cancer. 2005 Sep 9;4:32. doi: 10.1186/1476-4598-4-32.
4
hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands.hZip2和hZip3锌转运体在人前列腺腺癌腺体内表达下调。
Mol Cancer. 2007 Jun 5;6:37. doi: 10.1186/1476-4598-6-37.
5
Emerging Perspectives in Zinc Transporter Research in Prostate Cancer: An Updated Review.前列腺癌中锌转运体研究的新视角：最新综述
Nutrients. 2024 Jun 26;16(13):2026. doi: 10.3390/nu16132026.
6
The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.前列腺癌代谢的临床相关性；锌与肿瘤抑制：梳理其中的关联
Mol Cancer. 2006 May 15;5:17. doi: 10.1186/1476-4598-5-17.
7
The SLC39 family of zinc transporters.SLC39 家族锌转运体。
Mol Aspects Med. 2013 Apr-Jun;34(2-3):612-9. doi: 10.1016/j.mam.2012.05.011.
8
The families of zinc (SLC30 and SLC39) and copper (SLC31) transporters.锌（SLC30和SLC39）及铜（SLC31）转运蛋白家族。
Curr Top Membr. 2014;73:321-55. doi: 10.1016/B978-0-12-800223-0.00009-8.
9
Zinc and prostatic cancer.锌与前列腺癌。
Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):640-5. doi: 10.1097/MCO.0b013e32833106ee.
10
The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy.前列腺的中间代谢：理解前列腺恶性肿瘤发病机制和进展的关键。
Oncology. 2000 Nov;59(4):269-82. doi: 10.1159/000012183.
引用本文的文献
1
Zinc Transporters of the LIV-1 Subfamily in Various Cancers: Molecular Insights and Research Priorities for Saudi Arabia.LIV-1亚家族锌转运体在各类癌症中的研究：沙特阿拉伯的分子见解与研究重点
Int J Mol Sci. 2025 Aug 21;26(16):8080. doi: 10.3390/ijms26168080.
2
Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer.Lon蛋白酶1介导的代谢重编程促进前列腺癌进展。
Cell Death Dis. 2025 Feb 19;16(1):116. doi: 10.1038/s41419-025-07449-8.
3
Zinc and its binding proteins: essential roles and therapeutic potential.锌及其结合蛋白：重要作用与治疗潜力
Arch Toxicol. 2025 Jan;99(1):23-41. doi: 10.1007/s00204-024-03891-3. Epub 2024 Nov 7.
4
ENO2, a Glycolytic Enzyme, Contributes to Prostate Cancer Metastasis: A Systematic Review of Literature.糖酵解酶ENO2促进前列腺癌转移：文献系统综述
Cancers (Basel). 2024 Jul 10;16(14):2503. doi: 10.3390/cancers16142503.
5
Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc.乳腺癌和前列腺癌细胞对细胞外锌变化反应的分子见解
J Oncol. 2024 Jan 12;2024:9925970. doi: 10.1155/2024/9925970. eCollection 2024.
6
Study of Serum Copper and Zinc Levels and Serum Cu/Zn Ratio among Polish Women with Endometrial Cancer.波兰子宫内膜癌妇女血清铜锌水平及血清 Cu/Zn 比值的研究。
Nutrients. 2023 Dec 31;16(1):144. doi: 10.3390/nu16010144.
7
Multifunctional role of zinc in human health: an update.锌在人类健康中的多功能作用：最新进展
EXCLI J. 2023 Aug 4;22:809-827. doi: 10.17179/excli2023-6335. eCollection 2023.
8
Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer.解析前列腺癌中线粒体代谢与动力学的独特特征
Cancers (Basel). 2023 Feb 13;15(4):1192. doi: 10.3390/cancers15041192.
9
Zinc in Prostate Health and Disease: A Mini Review.锌与前列腺健康和疾病：一篇综述短文
Biomedicines. 2022 Dec 10;10(12):3206. doi: 10.3390/biomedicines10123206.
10
Urinary Zinc Loss Identifies Prostate Cancer Patients.尿锌流失可识别前列腺癌患者。
Cancers (Basel). 2022 Oct 28;14(21):5316. doi: 10.3390/cancers14215316.
本文引用的文献
1
Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model.TRAMP 前列腺癌动物模型中人前列腺癌 ZIP1/锌/柠檬酸盐的遗传代谢关系。
Cancer Biol Ther. 2011 Dec 15;12(12):1078-84. doi: 10.4161/cbt.12.12.18367.
2
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths.欧洲和美国在 PSA 时代前列腺癌的发病率、生存率和死亡率变化：额外诊断和避免死亡。
Ann Oncol. 2012 May;23(5):1325-1334. doi: 10.1093/annonc/mdr414. Epub 2011 Sep 28.
3
The role of zinc transporter ZIP4 in prostate carcinoma.锌转运蛋白 ZIP4 在前列腺癌中的作用。
Urol Oncol. 2012 Nov-Dec;30(6):906-11. doi: 10.1016/j.urolonc.2010.11.010. Epub 2011 Jul 30.
4
Diagnosis of prostate cancer using differentially expressed genes in stroma.利用基质中差异表达的基因诊断前列腺癌。
Cancer Res. 2011 Apr 1;71(7):2476-87. doi: 10.1158/0008-5472.CAN-10-2585.
5
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值：GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
6
Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands.锌在前列腺中的差异积累和人锌转运蛋白 1（hZIP1）的表达。
Methods. 2010 Dec;52(4):316-21. doi: 10.1016/j.ymeth.2010.08.004. Epub 2010 Aug 10.
7
In silico estimates of tissue components in surgical samples based on expression profiling data.基于表达谱数据的手术样本中组织成分的计算机预测。
Cancer Res. 2010 Aug 15;70(16):6448-55. doi: 10.1158/0008-5472.CAN-10-0021. Epub 2010 Jul 27.
8
New prospective for non-invasive detection, grading, size evaluation, and tumor location of prostate cancer.前列腺癌的无创性检测、分级、大小评估和肿瘤定位的新展望。
Prostate. 2010 Nov 1;70(15):1701-8. doi: 10.1002/pros.21205.
9
An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica.肠病性肢端皮炎中SLC39A4基因突变的最新研究进展。
Hum Mutat. 2009 Jun;30(6):926-33. doi: 10.1002/humu.20988.
10
The important role of the apoptotic effects of zinc in the development of cancers.锌的凋亡效应在癌症发展中的重要作用。
J Cell Biochem. 2009 Apr 1;106(5):750-7. doi: 10.1002/jcb.22049.
Zotero 插件